The Cost-Sharing Contributions for Prescriptions would prohibit discrimination against entities participating in the federal 340B drug pricing program. It states that pharmacy benefit managers and third parties cannot discriminate against entities that participate in the 340B program by: Reimbursing a covered entity less than it would an entity not covered by the 340B program,  Assessing covered entities fees or other assessments different from non-covered entities,  preventing or interfering with a patient’s right to use a 340B program drug from a covered entity,  Imposing different requirements for covered vs. non-covered entities, including: o requiring use of a pharmacy network, o requiring use of different audit procedures, o requiring claim procedures that would not be required of non-covered entities, or o charging additional fees or other provisions that would interfere with a patient’s right to receive a 340B drug from a covered entity.